CARDIAC MORPHOLOGIC AND FUNCTIONAL-CHANGES INDUCED BY EPIRUBICIN CHEMOTHERAPY

被引：50
作者：
DARDIR, MD
FERRANS, VJ
MIKHAEL, YS
ELGUINDY, MS
ELAASAR, AB
ELZAWAHRY, HM
ALLING, DW
BANKS, SM
ELMAWLA, NG
机构：
[1] IMBABA HEART INST, CAIRO, EGYPT
[2] NHLBI, PATHOL BRANCH, ULTRASTRUCT SECT, BETHESDA, MD 20205 USA
[3] UNIV CAIRO, KASR, EL AINI HOSP, DEPT CARDIOL, CAIRO, EGYPT
[4] UNIV CAIRO, NCI, DEPT TUMOR BIOL, CAIRO, EGYPT
[5] UNIV CAIRO, NCI, DEPT MED ONCOL, CAIRO, EGYPT
[6] NIAID, BETHESDA, MD 20205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 07期
关键词：
D O I：
10.1200/JCO.1989.7.7.947
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：947 / 958
页数：12
相关论文
共 51 条
[1]  
Billingham M., 1984, CANCER TREAT S, V3, P71
[2]  
BILLINGHAM ME, 1980, DRUG INDUCED HEART D, P138
[3]   TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].
BONFANTE, V ;
VILLANI, F ;
BONADONNA, G .
TUMORI JOURNAL, 1982, 68 (02) :105-111
[4]   EARLY ANTHRACYCLINE CARDIOTOXICITY [J].
BRISTOW, MR ;
THOMPSON, PD ;
MARTIN, RP ;
MASON, JW ;
BILLINGHAM, ME ;
HARRISON, DC .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (05) :823-832
[5]  
BRISTOW MR, 1978, CANCER TREAT REP, V62, P873
[6]  
BRISTOW MR, 1982, CANCER, V50, P32, DOI 10.1002/1097-0142(19820701)50:1<32::AID-CNCR2820500108>3.0.CO
[7]  
2-Q
[8]   DOSE-EFFECT AND STRUCTURE-FUNCTION-RELATIONSHIPS IN DOXORUBICIN CARDIOMYOPATHY [J].
BRISTOW, MR ;
MASON, JW ;
BILLINGHAM, ME ;
DANIELS, JR .
AMERICAN HEART JOURNAL, 1981, 102 (04) :709-718
[9]  
BUJA LM, 1973, CANCER-AM CANCER SOC, V32, P771, DOI 10.1002/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO
[10]  
2-A
123456